Period Ending | Dec 31, 2010 | Dec 31, 2009 |
---|
Total Revenue
|
-
|
3,000
| Cost of Revenue |
-
|
-
| |
Gross Profit
|
-
|
3,000
| |
|
Operating Expenses |
|
Research Development | 14,561 | 14,804 |
|
Selling General and Administrative | 6,039 | 3,934 |
|
Non Recurring |
-
|
-
|
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
(20,600)
|
(15,738)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,572 | 168 |
|
Earnings Before Interest And Taxes | (19,028) | (15,570) |
|
Interest Expense | 1,065 | 1,436 |
|
Income Before Tax | (20,093) | (17,006) |
|
Income Tax Expense |
-
|
-
|
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | (20,093) | (17,006) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
(20,093)
|
(17,006)
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
(20,093)
|
(17,006)
|
|